Aug 28, 2021 08:00 AM

Zhejiang Huahai Pharmaceutical Co.,Ltd.’s Net Profit Dropped 14.1% in First Half of 2021

Zhejiang Huahai Pharmaceutical Co.,Ltd. (浙江华海药业股份有限公司) (600521.SH) reported a net profit of 520.9 million yuan in the first half of 2021, down 14.1% year-on-year.

Meanwhile, the company posted 3 billion yuan in revenue, down 8.2% year-on-year.

At the end of the reporting period, it had 14.5 billion yuan in total assets and 7.5 billion yuan in total liabilities, with a liability-to-asset ratio of 52%.

This article was automatically produced by Caixin Automation on Sept. 1, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.

Share this article
Open WeChat and scan the QR code
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
Caixin Biz Roundup: China’s Covid Caseload Hits Six-Month High